(Q30972889)

27 June 2017

title

Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227. (English)

1 reference

27 June 2017

Julianne Berry

1

1 reference

27 June 2017

Lukeysha C Kline

series ordinal

2

1 reference

27 June 2017

John L Hart

series ordinal

3

1 reference

27 June 2017

Joel Sequeira

series ordinal

4

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Drug Development and Industrial Pharmacy

27 June 2017

published in

1 reference

27 June 2017

volume

29

1 reference

27 June 2017

issue

6

1 reference

27 June 2017

page(s)

631-639

1 reference

Innovations and perspectives of metered dose inhalers in pulmonary drug delivery

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Influence of Formulation on Aerosol Particle Size

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Drug-surfactant-propellant interactions in HFA-formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Transition to CFC-free metered dose inhalers--into the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Aerodynamic particle size of metered-dose inhalers determined by the quartz crystal microbalance and the Andersen cascade impactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Characterization of Medical Aerosols: Physical and Clinical Requirements for New Inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Modulation of aerosol clouds produced by pressurised inhalation aerosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120021312

21 January 2018

Identifiers

DOI

10.1081/DDC-120021312

1 reference

27 June 2017

1 reference